DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Nor-qd is a drug marketed by Teva Branded Pharm and is included in one NDA.
The generic ingredient in NOR-QD is norethindrone. There are twenty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
A generic version of NOR-QD was approved as norethindrone by GLENMARK GENERICS on July 22nd, 2010.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Teva Branded Pharm||NOR-QD||norethindrone||TABLET;ORAL-28||017060-001||Approved Prior to Jan 1, 1982||AB1||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|